Management advice for patients with reflux-like symptoms: an evidence-based consensus.

"Conflicts of interest All authors attended the online meetings funded by Reckitt Benckiser Healthcare Ltd. A.P.H. has served as a consultant for Sandoz and Tillotts, and Chair of Rome IV Primary Care Committee. R.Y. has served as a consultant for Medtronic, Phathom Pharmaceuticals, StatLinkMD, and Medscape, has received research support from Ironwood Pharmaceuticals and is on the advisory board with stock options for RJS Mediagnostix. F.A. is a member of the Programme for NASH in Primary Health Care at the University of Crete, funded by Gilead. A.B. has received research funding from Nutricia, Norgine, Dr Falk Pharma, Thelial, and SST and received speaker and/or consulting fees from Laborie, Medtronic, Dr Falk Pharma, Reckitt, Alimentiv, Sanofi/Regeneron and AstraZeneca. H.E. has received research funding from Phathom. P.F. has received conference fees from Schwabe Pharma. J.M.M. has participated in educational activities funded by Reckitt Benckiser Healthcare Ltd. E.V.S. has served as speaker for Abbvie, Agave, AGPharma, Alfasigma, Aurora Pharma, CaDiGroup, Celltrion, Dr Falk Pharma, for example, Stada Group, Fenix Pharma, Fresenius Kabi, Galapagos, Janssen, JB Pharmaceuticals, Innovamedica/Adacyte, Malesci, Mayoly Biohealth, Omega Pharma, Pfizer, Reckitt Benckiser, Sandoz, SILA, Sofar, Takeda, Tillots, Unifarco; has served as a consultant for Abbvie, Agave, Alfasigma, Biogen, Bristol-Myers Squibb, Celltrion, Diadema Farmaceutici, Dr Falk Pharma, Fenix Pharma, Fresenius Kabi, Janssen, JB Pharmaceuticals, Merck & Co, Reckitt Benckiser, Regeneron, Sanofi, SILA, Sofar, Synformulas GmbH, Takeda, Unifarco; he received research support from Pfizer, Reckitt Benckiser, SILA, Sofar, Unifarco, Zeta Farmaceutici. D.S. has received research grants from Reckitt Benckiser Healthcare Ltd, Jinshan Technology (China), and Alfa Sigma (Italy). M.U. has served as speaker for Sanofi, Terapia, Servier, Berlin-Chemie, Ipsen, Bayer, Abbvie. P.J.K. has served as a consultant for Ironwood and Reckitt."

"Editorial assistance was provided by Lisa O’Rourke PhD of Lumanity, UK, and funded by Reckitt Benckiser Healthcare Ltd. Conflicts of interestAll authors attended the online meetings funded by Reckitt Benckiser Healthcare Ltd. A.P.H. has served as a consultant for Sandoz and Tillotts, and Chair of Rome IV Primary Care Committee. R.Y. has served as a consultant for Medtronic, Phathom Pharmaceuticals, StatLinkMD, and Medscape, has received research support from Ironwood Pharmaceuticals and is on the advisory board with stock options for RJS Mediagnostix. F.A. is a member of the Programme for NASH in Primary Health Care at the University of Crete, funded by Gilead. A.B. has received research funding from Nutricia, Norgine, Dr Falk Pharma, Thelial, and SST and received speaker and/or consulting fees from Laborie, Medtronic, Dr Falk Pharma, Reckitt, Alimentiv, Sanofi/Regeneron and AstraZeneca. H.E. has received research funding from Phathom. P.F. has received conference fees from Schwabe Pharma. J.M.M. has participated in educational activities funded by Reckitt Benckiser Healthcare Ltd. E.V.S. has served as speaker for Abbvie, Agave, AGPharma, Alfasigma, Aurora Pharma, CaDiGroup, Celltrion, Dr Falk Pharma, for example, Stada Group, Fenix Pharma, Fresenius Kabi, Galapagos, Janssen, JB Pharmaceuticals, Innovamedica/Adacyte, Malesci, Mayoly Biohealth, Omega Pharma, Pfizer, Reckitt Benckiser, Sandoz, SILA, Sofar, Takeda, Tillots, Unifarco; has served as a consultant for Abbvie, Agave, Alfasigma, Biogen, Bristol-Myers Squibb, Celltrion, Diadema Farmaceutici, Dr Falk Pharma, Fenix Pharma, Fresenius Kabi, Janssen, JB Pharmaceuticals, Merck & Co, Reckitt Benckiser, Regeneron, Sanofi, SILA, Sofar, Synformulas GmbH, Takeda, Unifarco; he received research support from Pfizer, Reckitt Benckiser, SILA, Sofar, Unifarco, Zeta Farmaceutici. D.S. has received research grants from Reckitt Benckiser Healthcare Ltd, Jinshan Technology (China), and Alfa Sigma (Italy). M.U. has served as speaker for Sanofi, Terapia, Servier, Berlin-Chemie, Ipsen, Bayer, Abbvie. P.J.K. has served as a consultant for Ironwood and Reckitt."